There continues to be a debate in the scientific community about the role that angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers play in coronavirus disease 2019 infection.
Simon Murray, MD
Advertisement
Articles by Simon Murray, MD
Hydroxychloroquine and remdesivir have been caught up in the rush to develop an effective treatment for COVID-19.
The state attorney general’s office and its State Board of Medical Examiners are limiting pharmacists and physicians from allowing patients to use certain medications for COVID-19.
An effective treatment plan for squamous cell carcinoma best undertaken by a group of practitioners.
Advertisement
Latest Updated Articles
Pharmacists Can Play an Important Role in Treating Skin CancerJanuary 7th 2020
Clinical Updates on Potential COVID-19 TreatmentsApril 27th 2020
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Accepts NDA for AD109 to Treat of Adults With Obstructive Sleep Apnea
2
Men Face Higher Odds of Later-Stage Diagnosis Across 20 Cancer Types
3
Investigational mRNA Flu Vaccine Broadens Antibody Defenses, Sustains Immune "Training Hub" Longer Than Standard Shot
4
FDA Approves Enlicitide, the First Oral PCSK9 Inhibitor for High Cholesterol
5